Key result
Diabetes and QRS duration link to walking distance in HF patients undergoing CRT.
Why the study?
Cardiac resynchronization therapy candidates have variable responses, and simpler functional tests like the 6 min walk test may help predict outcomes and guide treatment adjustments.
Do clinical and electrocardiographic parameters predict 6-minute walk test performance in heart failure patients undergoing cardiac resynchronization therapy?
Observational (n=69)
No
Do clinical and electrocardiographic parameters predict 6-minute walk test performance in heart failure patients undergoing cardiac resynchronization therapy?
Clinical factors like diabetes and electrocardiographic parameters such as QRS duration, QRS area, and R/S ratio may serve as predictors for functional response to cardiac resynchronization therapy.
Answers are grounded in this paper and cite their sources.
May aid CRT candidate selection for functional gains; hypothesis-generating and requires prospective validation before practice change.
Background: Cardiac resynchronization therapy is an essential treatment for heart failure patients. Candidates typically have cardiomyopathy accompanied by delayed electrical activation in the left ventricular lateral wall, causing uncoordinated contractions and worsening heart failure. Heart failure severity can be assessed with functional tests: the cardiopulmonary test, which is a maximal exercise test, remains the gold standard, but the 6 min walk test has emerged as an easier, faster, and more comfortable alternative to be used by clinicians to adjust treatment protocols for cardiovascular and pulmonary conditions. Methods: This is a prospective observational study that included 69 patients from a single healthcare facility, and the purpose was to determine if the 6 min walk test results could be associated with changes in various electrocardiographic, clinical, functional, and demographic parameters. All the parameters and the 6 min walk distance were recorded at four key time moments: before the procedure and after 6, 9, and 12 months. The electrocardiographic parameters were obtained from the patients’ electrocardiograms recorded in the four key moments and included variables such as QRS area, duration, percentage of biventricular pacing, and many others, while the functional variables included the monitored intraprocedural systolic blood pressure and the end-systolic left ventricular volume. We also aimed to check if clinical conditions such as diabetes and chronic kidney disease and demographic variables such as age or sex have any impact. Results and Conclusions: All this research was performed in order to identify which parameters hold a predictive value and can serve as future criteria for better patient selection and for defining a proper resynchronization outcome. The study shows that parameters such as diabetes and QRS duration have an impact over the 6 min walk distance. Also, newer variables such as the QRS area and the R/S ratio may represent a direction worth studying in order to predict the outcomes of cardiac resynchronization therapy.
No takes yet. Share an insight, caveat, or question.
Rosu et al. (2024) conducted an observational in Heart failure (n=69). Clinical and electrocardiographic parameters (e.g., diabetes, QRS duration) was evaluated on 6 min walk distance. Clinical and electrocardiographic parameters, including diabetes and QRS duration, impacted the walking distance in heart failure patients undergoing cardiac resynchronization therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: